Ocular Therapeutix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Ocular Therapeutix 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About OCUL

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. 

CEO
Pravin U. Dugel
CEOPravin U. Dugel
Employees
274
Employees274
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2006
Founded2006
Employees
274
Employees274

OCUL Key Statistics

Market cap
2.04B
Market cap2.04B
Price-Earnings ratio
-6.37
Price-Earnings ratio-6.37
Dividend yield
Dividend yield
Average volume
5.20M
Average volume5.20M
High today
$9.34
High today$9.34
Low today
$8.93
Low today$8.93
Open price
$9.08
Open price$9.08
Volume
4.10M
Volume4.10M
52 Week high
$16.44
52 Week high$16.44
52 Week low
$5.79
52 Week low$5.79

Stock Snapshot

The current Ocular Therapeutix(OCUL) stock price is $9.20, with a market capitalization of 2.04B. The stock trades at a price-to-earnings (P/E) ratio of -6.37.

As of 2026-02-08, Ocular Therapeutix(OCUL) stock has fluctuated between $8.93 and $9.34. The current price stands at $9.20, placing the stock +3.0% above today's low and -1.5% off the high.

The Ocular Therapeutix(OCUL)'s current trading volume is 4.1M, compared to an average daily volume of 5.2M.

During the past year, Ocular Therapeutix(OCUL) stock moved between $5.79 at its lowest and $16.44 at its peak.

During the past year, Ocular Therapeutix(OCUL) stock moved between $5.79 at its lowest and $16.44 at its peak.

OCUL News

Simply Wall St 2d
Assessing Ocular Therapeutix Valuation After Recent Share Price Volatility

Ocular Therapeutix (OCUL) has been drawing attention after recent share price swings, with the stock up about 4.2% over the past day but down over the past week...

Assessing Ocular Therapeutix Valuation After Recent Share Price Volatility

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OCUL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.